VasSol
VasSol, Inc. provides non-invasive vascular analysis tech for diagnosing and treating vascular diseases, founded in 1999.
Founded
1999VasSol, Inc. provides non-invasive vascular analysis tech for diagnosing and treating vascular diseases, founded in 1999.
VasSol, Inc., founded in 1999, is dedicated to advancing vascular analysis technology to aid clinicians in diagnosing and treating vascular diseases. The company's core mission is to provide non-invasive solutions for quantifying blood flow in the brain and other vascular regions. Their flagship product, NOVA (Non-invasive Optimal Vessel Analysis), utilizes magnetic resonance angiography and imaging to create 3D models of blood vessels and measure volumetric blood flow rates. VasSol's technology is applicable in cerebrovascular, renal, and peripheral vascular conditions, targeting healthcare providers who need precise vascular diagnostics.
Notable figures associated with VasSol include its founders and key investors who have supported the development of its pioneering technology. The company has achieved significant milestones, such as demonstrating NOVA's effectiveness as an independent predictor of recurrent stroke in an NIH study. VasSol's impact is evident in its contribution to non-invasive vascular diagnostics, providing clinicians with critical tools to improve patient outcomes in various vascular diseases.
Companies similar to VasSol include VasoGnosis, Vaso, BlueDop Medical and NovaSignal.
VasSol was founded in 1999.
VasSol's headquarters is located in River Forest, IL, US.
VasSol's most recent funding round was for $928.3k (USD) in March 2011.
As of Mar 11, 2011, VasSol has disclosed funding of $928.3k (USD). Undisclosed round amounts are excluded.
VasSol has 9 employees as of Feb 5, 2024.
novasignal.com
